Patient ID No. | Sex/ Age (years) | ECOG PS | IELSG score* | Disease state | Previous therapy | Tumor location | R-B(O)ADÂ cycles completed | Final response | PFS/OS (months) |
---|---|---|---|---|---|---|---|---|---|
1 | F/68 | 2 | 5 | Ref | HDMTX+ AraC | D; periventricular, basal ganglia | 3 | PD | 1.8/7.3 |
2 | F/55 | 2 | 4 | Ref | HDMTX+ AraC | D; periventricular, corpus callosum | 2 | PD | 2.5/6.8 |
3 | M/75 | 1 | 4 | Rel | HDMTX + WBRT; MPV-A | ND; L optic nerve | 4 | CR | 21.7/> 21.7 |
4 | M/42 | 2 | 3 | Ref | HDMTX | D; basal ganglia | 2 | PD | 1.6/9.1 |
5 | M/78 | 2 | 3 | Rel | HDMTX+ AraC | ND; L parietal | 4 | PR | 6.9/> 6.9 |
6 | F/55 | 2 | 4 | Ref | HDMTX+ AraC | ND; L frontal, R temporal | 3 | PD | 2.8/3.3 |
7 | F/47 | 1 | 2 | Ref | HDMTX+ AraC | Dt; L frontal, periventricular | 1 | PR | 2.8/2.8 |
8 | F/73 | 2 | 5 | Rel | HDMTX+ AraC | ND; L frontal | 4 | PR | 4.4/4.4 |
9 | M/75 | 2 | 4 | Ref | HDMTX+ AraC | NDt; L frontal | 2 | SD | 4.2/> 4.2 |
10 | M/65 | 2 | 5 | Ref | HDMTX | Dt; L frontal, basal ganglia | 2 | PR | 3.9/3.9 |